WHO praises AstraZeneca COVID-19 vaccine trial pause
Tweet
Share
E-mail
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration
GENEVA (Reuters) - A World Health Organization official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus vaccine after an unexplained illness showed the firm was prioritising safety.
"This is what we want to see with trials, it is a well-run trial. Safety is always critical, it is crucial and they have looked at that in an appropriate manner," Margaret Harris told journalists in Geneva.
Asked to react to experimental COVID-19 vaccine use in China and Russia, she said: "The WHO would like to see vaccines go head to head so we can have clear information and to see these results against each other."
(Reporting by Emma Farge, editing by Louise Heavens)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
- AMC CEO threatens SEC complaint over Robinhood tokens
- Dell’s earning report was bullish for Intel CPU demand, analyst says
Create E-mail Alert Related Categories
General News, ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
